Spyre Therapeutics
SYRE
SYRE
87 hedge funds and large institutions have $352M invested in Spyre Therapeutics in 2020 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 43 increasing their positions, 13 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
24% more funds holding
Funds holding: 70 → 87 (+17)
0.58% more ownership
Funds ownership: 2.83% → 3.41% (+0.58%)
Holders
87
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$25M | |
| 2 | +$24.7M | |
| 3 | +$13.2M | |
| 4 |
BlackRock
New York
|
+$12.1M |
| 5 |
O
OrbiMed
New York
|
+$10.6M |
Top Sellers
| 1 | -$1.54M | |
| 2 | -$534K | |
| 3 | -$462K | |
| 4 |
Renaissance Technologies
New York
|
-$422K |
| 5 |
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO)
Austin,
Texas
|
-$398K |